The final FDA clinical trial met both of its primary efficacy endpoints, demonstrating a statistically significant improvement in the symptom endpoint of ocular discomfort after two weeks of treatment.
New Drug Approved for the Short-Term Treatment of Dry Eye Disease
New Neurostimulation Device Approved for Dry Eye Disease
Use visual tools to explain this treatment option to patients The COVID-19 pandemic has had a negative impact on our eyes. Dry eye...